Neutropenia and G-CSF use in patients receiving FOLFOX during the COVID-19 pandemic
Journal of Oncology Pharmacy Practice
Published online on March 26, 2026
Abstract
Journal of Oncology Pharmacy Practice, Ahead of Print.
BackgroundDuring the COVID-19 pandemic, guidance broadened indications for primary G-CSF prophylaxis to reduce chemotherapy-related neutropenia while minimizing clinic visits. Evidence on the optimal duration of daily G-CSF in biweekly FOLFOX remains ...
BackgroundDuring the COVID-19 pandemic, guidance broadened indications for primary G-CSF prophylaxis to reduce chemotherapy-related neutropenia while minimizing clinic visits. Evidence on the optimal duration of daily G-CSF in biweekly FOLFOX remains ...